HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer
HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update
HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update
HanAll to Present at Korea Bio Investment Conference 2021
HanAll to Present at Korea Bio Investment Conference 2021
HanAll Biopharma Reports Third Quarter 2021 Results
HanAll Biopharma Reports Third Quarter 2021 Results
HanAll\'s Partner HBM Completes First Dosing of Phase 2 of Batoclimab in TED in China
HanAll\'s Partner HBM Completes First Dosing of Phase 2 of Batoclimab in TED in China
HanAll\'s Partner HBM Announces IND Approval for Phase 2 of Batoclimab in CIDP in China
HanAll\'s Partner HBM Announces IND Approval for Phase 2 of Batoclimab in CIDP in China